Beruflich Dokumente
Kultur Dokumente
A common problem
by
Dr/ khalid s ramadan
Internist
Zagazig University Hospitals , Egypt
Mouwasat Hospital Dammam, KSA
TAKE HOME MESSAGE
DON’T LET
PERSISTENT
PROTEINURIA GO
UNQUANTIFIED OR
UNEVALUATED!
Definition
Proteinuria is defined as excess serum protein excreted in
the urine.
Normal protein excretion
< 150 mg total protein/d and ~30 mg albumin/d
Microalbuminuria
30–300 mg albumin/d
Also defined as 30–300 μg albumin/mg creatinine
It is not detectable by dipstick analysis.
Albuminuria and moderate proteinuria
300–3500 mg albumin/d
Nephrotic-range proteinuria
>3500 mg albumin/d
Isolated proteinuria
Proteinuria in the presence of an otherwise normal
urinary sediment, a radiologically normal urinary
tract, and absence of known renal disease
Physiology/Pathophysiol
ogy
• Protein flow through renal arteries =
121,000 g/day
• Protein filtered through glomerulus = 1-2
g/day (< 0.001%)
• Protein excreted in urine < 150 mg/day
(<1% of filtered)
• Composition of normal urine: Tamm-
Horsfall protein 60-80%, albumin 10-20%.
Magnitude of proteinuria and protein
composition depends on the
mechanism of renal injury
• BP and weight
• Fundoscopic exam
• Cardiopulmonary exam
• Rashes
• Edema
Clinical Evaluation
Urine dipstick
• Urine dipstick primarily detects albumin
• positive urine dipstick test usually
suggests overt proteinuria.
• Dipstick testing is also unlikely to detect
excretion of smaller proteins
characteristic of tubular and overflow
proteinuria
• Persistent proteinuria is a sign of a
glomerular disorder and requires further
testing
Clinical Evaluation
Sulfosalicylic Acid (SSA)
Assay
A s s e s s m e n t o f
P r o t e i n u r ia
D ip s t ic k p o s it iv e S S A p o s it iv e
S S A n e g a t iv e b u t d ip s t ic k n e g a t iv e
o r d is p r o p o r t i o n a t e ly
s m a ll
T r a n s ie n t o r O v e r f lo w
p e r s is t e n t? p ro te i n u r ia
( C o n fir m o n ( L ig h t c h a in s ,
2 4 h r u r i n e o r s p o t r a t io ly s o z y m u r ia , e tc
T r a n s ie n t: P e r s is t e n t
P e r i o d ic
re a s s e s s m e n t
O r t h o s t a t ic F ix e d
R e a s s u ra n c e , F u r t h e r e v a lu a t io n
P e r i o d ic ( R e n a l u lt r a s o u n d ,
R e a s s e s s m e n t N e p r h o lo g y
R e f e r r a l)
MANAGEMENT OF
PROTEINURIA
Management
broad lines
• Blood pressure control
• Diabetic control
• ACEI ,, calcium channel
blockers
• Lipid control
• Dietary protein restriction
Management
ACE Inhibitors
• Have benefit over and above blood
pressure control.
• Type I Diabetes: Captopril use associated
with slower progression, less proteinuria
with or without co-existing HTN (Lewis et
al, 1993, Viberti et al, 1994)
• Type II Diabetes: Enalapril use associated
with slower progression, less proteinuria.
(Ravid et al, 1993, 1996).
Management
ACE Inhibitors
• Nondiabetic disease: use of
benazepril vs. placebo reduced by
38% the 3-yr progression of renal
failure in various diseases.
Reduction greater with higher
proteinuria (Maschio et al, 1996).
• Similar data emerging for
angiotensin II receptor antagonists.
Screening of proteinuria in
diabetic patient
Prognosis
• Diabetic nephropathy: progression to ESRD
over 10-20 years after onset of proteinuria.